Trial
NCT00574951
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Gynecologic Oncology Group
Collaborators
National Cancer Institute (NCI)
Condition
Fallopian Tube Cancer
Intervention
motesanib diphosphate
Why stopped
Study was stopped for severe toxicity causing concern for patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-11